<DOC>
	<DOCNO>NCT00287833</DOCNO>
	<brief_summary>This randomized phase I trial study side effect best dose Bowman-Birk inhibitor concentrate prevent cancer healthy men . Chemoprevention use certain drug keep cancer forming , grow , come back . The use Bowman-Birk inhibitor concentrate may prevent cancer .</brief_summary>
	<brief_title>Bowman-Birk Inhibitor Concentrate Preventing Cancer Healthy Men</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Determine toxic effect Bowman-Birk inhibitor concentrate , administer orange juice suspension , healthy male participant . II . Determine safe dose range drug participant . III . Determine recommend phase II dose drug participant . SECONDARY OBJECTIVES : I . Determine pharmacokinetics drug participant . OUTLINE : This randomize , placebo-controlled , double-blind , dose-escalation study . Participants sequentially assign 1 4 dose level cohort . One participant dose level cohort randomize receive placebo . Participants receive 1 4 escalating dos oral Bowman-Birk inhibitor concentrate placebo , orange juice suspension , day 1 . After completion study treatment , participant follow periodically 4 week .</detailed_description>
	<criteria>Healthy volunteer Male Performance status ECOG 02 RBC normal WBC ≥ 3,000/mm^3 Platelet count normal Hemoglobin normal Hematocrit normal ALT AST normal Bilirubin normal Creatinine normal No history heart disease EKG normal No history pancreatitis obstruction pancreatic ducts No history pancreatic cancer pancreatic adenoma Amylase normal Lipase normal Cholesterol normal Triglycerides normal Serum glucose ± 10 % normal Within 15 % ideal body weight No history chronic medical condition No history excessive alcohol consumption ( i.e. , &gt; 2 alcoholic beverage per day average ) No history amyloidosis Nonsmoker Former smoker eligible provide smoke within past 3 month No history medical condition would influence gastrointestinal uptake study drug No history diabetes mellitus No allergy prior adverse reaction soybean Not vegetarian No diagnosis cancer within past 5 year except nonmelanoma skin cancer No evidence lifethreatening disease No evidence psychiatric problem More 12 month since prior chemotherapy More 1 month since prior experimental drug More 3 day since prior consumption alcoholic beverage More 2 week since prior concurrent regular use ( i.e. , &gt; 3 times/week ) nonsteroidal antiinflammatory drug More 2 week since prior multivitamin tablet ( vitamin supplement ) &gt; 2 per day No 2 multivitamin tablet ( vitamin supplement ) per day study participation No 1 serve tofu , soy milk , primarily soybased food per day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>